AKT1 and cancer: Frequent deregulation of the PI3K–Akt pathway in cancer has prompted significant interest in blocking this pathway to prevent and/or treat cancer [18,19,20], as specific inhibition of the activation of Akt by small molecules may be a valid approach to prevent and/or treat human malignancies.